24
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T13148 |
CHK-IN-1
|
Chk | Cell Cycle/Checkpoint |
CHK-IN-1 是一种具有抗增殖活性的 CHK1 和 CHK2 双重抑制剂。 | |||
T10791 |
CHK1-IN-3
|
Chk | Cell Cycle/Checkpoint |
CHK1-IN-3 是一种检测点激酶 (CHK1) 抑制剂,IC50 值为 0.4 nM。 | |||
T79874 |
CHK-336
|
||
CHK-336(Example 1)为口服活性LDHA抑制剂(IC50<1 nM),有效抑制小鼠肝细胞产生乳酸。该化合物适用于高草酸尿症相关研究。 | |||
T40091 |
Chk1-IN-6
Chk1-IN-6 |
||
Chk1-IN-6 is a potent, selective, and orally bioavailable CHK1 inhibitor candidate. | |||
T37098 |
Chk1-IN-5
Chk1-IN-5 |
||
Chk1-IN-5 is a highly effective inhibitor of checkpoint kinase 1 (Chk1), which hinders the phosphorylation of Chk1 and effectively suppresses tumor growth in a colon cancer xenograft model[1]. | |||
T7080 |
CCT245737
SRA737 |
Chk | Cell Cycle/Checkpoint |
CCT245737 (SRA737) 是一种具有口服活性的选择性 Chk1 抑制剂,IC50值为 1.3 nM。 | |||
T6093 |
AZD-7762
AZD7762 |
Chk | Cell Cycle/Checkpoint |
AZD-7762 是一种有效的 ATP 竞争性的细胞周期检测点激酶抑制剂,抑制 Chk1的 IC50为 5 nM。 | |||
T10792L |
CHK1-IN-4 hydrochloride
CHK1-IN-4 hydrochloride(2120398-41-4 Free base) |
Chk | Cell Cycle/Checkpoint |
CHK1-IN-4 hydrochloride 是有效的checkpoint kinase 1 (chk1) 抑制剂,对肿瘤细胞中 chk1 磷酸化具有有效的抑制作用。CHK1-IN-4 hydrochloride 显示出抗肿瘤活性。 | |||
T21331 |
SAR-020106
|
Chk | Cell Cycle/Checkpoint |
SAR-020106 是一种强效、ATP 竞争性和选择性 CHK1 抑制剂,IC50为 13.3 nM。它对 CHK2 具有良好的选择性,可通过选择抗癌药物增强抗肿瘤活性。 | |||
T2517 |
SCH900776
MK 8776,MK-8776 |
Chk; CDK | Cell Cycle/Checkpoint |
SCH900776 (MK-8776) 是一种靶向细胞周期检查点激酶 1(Chk1) 的抑制剂,IC50值为 3 nM。它比对 CDK2 和 Chk2 的选择性分别高 50 和 500 倍,具有潜在的放射增敏和化学增敏活性。 | |||
T6084 |
Rabusertib
LY2603618,IC-83 |
Chk; PDK; Autophagy | Autophagy; Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling |
Rabusertib (IC-83) 是一种有效的选择性的Chk1抑制剂,IC50为 7 nM。它有潜在的化学增强活性,用于各种癌症和肿瘤治疗的试验。 | |||
T6350 |
CHIR-124
CHIR124,CHIR 124 |
Apoptosis; GSK-3; FLT; Chk; PDGFR; Src | Angiogenesis; Apoptosis; Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells; Tyrosine Kinase/Adaptors |
CHIR-124 是一种选择性 Chk1抑制剂,IC50值为 0.3 nM,可有效抑制 PDGFR 和 FLT3,IC50值分别为 6.6 nM 和 5.8 nM。 | |||
T2033 |
BML-277
C 3742,Chk2 Inhibitor II,BML 277 |
Apoptosis; Chk | Apoptosis; Cell Cycle/Checkpoint |
BML-277 (C 3742) 是一种选择性的检测点激酶 2 抑制剂,IC50为 15 nM。 | |||
T7300 |
GDC-0575
ARRY-575,RG7741 |
Chk | Cell Cycle/Checkpoint |
GDC-0575 (ARRY-575) 是一种高选择性,有口服活性的小分子Chk1抑制剂,IC50值为1.2 nM。 | |||
T10790 |
CHK1-IN-2
|
Chk | Cell Cycle/Checkpoint |
CHK1-IN-2 is an inhibitor of checkpoint kinase 1 (CHK1; IC50: 6 nM). | |||
T10792 |
CHK1-IN-4
|
Chk | Cell Cycle/Checkpoint |
CHK1-IN-4 is a potent inhibitor of checkpoint kinase 1 (chk1) and potently inhibits chk1 phosphorylation in the tumor cells with anti-tumor activity. | |||
T10793 |
CHK1 inhibitor
GDC-0575 analog |
Chk | Cell Cycle/Checkpoint |
CHK1 inhibitor (GDC-0575 analog) is a CHK1 inhibitor. | |||
T4327 |
Prexasertib dihydrochloride
LY2606368 (dihydrochloride),Prexasertib HCl,LY2606368 |
Apoptosis; Chk; S6 Kinase | Apoptosis; Cell Cycle/Checkpoint; MAPK; PI3K/Akt/mTOR signaling |
Prexasertib dihydrochloride (LY2606368) 是一种选择性的,ATP 竞争性的细胞周期检测点激酶 1 抑制剂,Ki 为 0.9 nM,IC50为 <1 nM。它抑制 CHK2(IC50=8 nM) 和 RSK1 (IC50=9 nM)。它引起双链 DNA 断裂和复制突变,导致细胞凋亡,有抗肿瘤活性。 | |||
T4310 |
Prexasertib
5-[[5-[2-(3-氨基丙氧基)-6-甲氧基苯基]-1H-吡唑-3-基]氨基]-2-吡嗪甲腈,LY2606368 |
Apoptosis; Chk | Apoptosis; Cell Cycle/Checkpoint |
Prexasertib (LY2606368) 是一种具有潜在抗肿瘤活性的检查点激酶 1 抑制剂。它可引起双链 DNA 断裂和复制突变,导致细胞凋亡。 | |||
T82393 | FLT3/CHK1-IN-1 | ||
FLT3/CHK-IN-1(Compound 18)为FLT3/CHK1双重抑制剂,其对c-KIT的选择性超1700倍,同时显著降低对hERG的亲和力,IC50为58.4 μM。在MV-4-11细胞接种小鼠异种移植模型中有效抑制肿瘤生长。 | |||
T6028 |
PF 477736
PF 00477736,PF-477736,PF-736,PF-00477736,PF477736 |
c-Fms; VEGFR; FGFR; FLT; c-RET; Chk; CDK; Src; Aurora Kinase | Angiogenesis; Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Tyrosine Kinase/Adaptors |
PF 477736 (PF-736,PF-00477736) 是一种特异性、有效且具有 ATP 竞争性的 Chk1 抑制剂,Ki 值为0.49 nM。它也是Chk2抑制剂,Ki 值为 47 nM。它还抑制VEGFR2、Fms、Yes、Aurora-A、FGFR3、Flt3和Ret。 | |||
T34577 |
Schkuhriolide
|
||
Schkuhriolide is a melampolide. | |||
T29083 |
V-11-0711
V 11-0711,V110711,V-110711,V11-0711,V 110711 |
||
V-11-0711 is an inhibitor of Chk-α, which may be essential in cancer cell proliferation. | |||
T80132 |
CBP501 Affinity Peptide
|
||
CBP501 Affinity Peptide为Chk激酶抑制剂,具有消除DNA损伤剂诱导的G2停滞作用,主要应用于癌症研究领域。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T83321 |
4-Demethyldeoxypodophyllotoxin
|
Chk | Cell Cycle/Checkpoint |
4-Demethyldeoxypodophyllotoxin 是一种来自 Podophyllum peltatum 根部的芳基四氢萘木酚素类化合物,具有抗癌活性,可调节 MCF-7乳腺癌细胞中的Chk-2信号通路。 |